What is the address of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS?

The registered office of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS is located at Rue Libon 5, 4800 Verviers.

Is DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS still active?

Yes. According to the CBE (1 October 2026) DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS is active, legal situation “Normale toestand”, started on 22 November 2006.

Is DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS registered on Peppol?

Yes, DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS is registered on the Peppol network with ID 0208:0885155781.

What is the enterprise number of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS?

The enterprise number of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS is BE0885155781.

When was DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS founded?

DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS was founded on 22 November 2006.

Who are the directors of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS?

According to the 2025 annual accounts, the directors of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS are: KATRAS CONSULT SRL.

Is DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 November 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS make in 2025?

DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS posted a profit after taxes of € 1,454 in financial year 2025.

What is the revenue of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS?

As a small company, DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,492.

DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS (Private Limited)

Dossier DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS, printed on 1 October 2026 from databakkes.be/en/0885155781/docteur-schils-neurosurgical-solutions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS from Verviers, company number BE0885155781, closed financial year 2025 with a result of € 1,454 after tax. For that financial year DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS recorded a gross margin of € 2,492 and equity of € 6,398. Compared with financial year 2024, the result moved from € 6,656 to € 1,454. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 6,398

▲ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,454

▼ 78% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,068

▲ 58% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -12,202.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,046

▲ 121% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,241 Gross margin 2022: € 1,241 First fiscal year in the series	€ -2,745 Gross margin 2023: € -2,745 ▼ € 3,986 vs 2022 (€ 1,241) Unfavourable step	€ 9,702 Gross margin 2024: € 9,702 ▲ € 12,447 vs 2023 (€ -2,745) Favourable step	€ 2,492 Gross margin 2025: € 2,492 ▼ 74% vs 2024 (€ 9,702) Unfavourable step	▼ 74%
Profit after taxes	€ -632 Profit after taxes 2022: € -632 First fiscal year in the series	€ -4,778 Profit after taxes 2023: € -4,778 ▼ € 4,146 vs 2022 (€ -632) Unfavourable step	€ 6,656 Profit after taxes 2024: € 6,656 ▲ € 11,434 vs 2023 (€ -4,778) Favourable step	€ 1,454 Profit after taxes 2025: € 1,454 ▼ 78% vs 2024 (€ 6,656) Unfavourable step	▼ 78%
Equity	€ 3,066 Equity 2022: € 3,066 First fiscal year in the series	€ -1,712 Equity 2023: € -1,712 ▼ € 4,778 vs 2022 (€ 3,066) Unfavourable step	€ 4,945 Equity 2024: € 4,945 ▲ € 6,657 vs 2023 (€ -1,712) Favourable step	€ 6,398 Equity 2025: € 6,398 ▲ 29% vs 2024 (€ 4,945) Favourable step	▲ 29%
Total debts	€ 673 Total debts 2022: € 673 First fiscal year in the series	€ 3,926 Total debts 2023: € 3,926 ▲ € 3,253 vs 2022 (€ 673) Unfavourable step	€ 3,952 Total debts 2024: € 3,952 ▲ 1% vs 2023 (€ 3,926) Unfavourable step	€ 6,170 Total debts 2025: € 6,170 ▲ 56% vs 2024 (€ 3,952) Unfavourable step	▲ 56%
Cash	€ 668 Cash 2022: € 668 First fiscal year in the series	€ 307 Cash 2023: € 307 ▼ 54% vs 2022 (€ 668) Unfavourable step	€ 7,645 Cash 2024: € 7,645 ▲ € 7,338 vs 2023 (€ 307) Favourable step	€ 12,068 Cash 2025: € 12,068 ▲ 58% vs 2024 (€ 7,645) Favourable step	▲ 58%
Retained profit	€ -15,534 Retained profit 2022: € -15,534 First fiscal year in the series	€ -20,312 Retained profit 2023: € -20,312 ▼ € 4,778 vs 2022 (€ -15,534) Unfavourable step	€ -13,655 Retained profit 2024: € -13,655 ▲ € 6,657 vs 2023 (€ -20,312) Favourable step	€ -12,202 Retained profit 2025: € -12,202 ▲ € 1,454 vs 2024 (€ -13,655) Favourable step	▲ € 1,454
Balance sheet total	€ 3,739 Balance sheet total 2022: € 3,739 First fiscal year in the series	€ 2,214 Balance sheet total 2023: € 2,214 ▼ 41% vs 2022 (€ 3,739) Unchanged	€ 8,896 Balance sheet total 2024: € 8,896 ▲ € 6,682 vs 2023 (€ 2,214) Unchanged	€ 12,568 Balance sheet total 2025: € 12,568 ▲ 41% vs 2024 (€ 8,896) Unchanged	▲ 41%

Key figures of DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS?

What happened at DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 1,454 (▼ 78% vs 2024). filed late Source: NBB ↗
Nov 22, 2006 Start of the company according to the CBE. KBO
Nov 15, 2006 New establishment in Verviers. KBO

In short

From € 632 loss in 2022 to € 1,454 profit in 2025.

Best year ever: 2024, with € 6,656 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS? We notify you, reason included.

Follow DOCTEUR SCHILS NEUROSURGICAL SOLUTIONS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit